PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. financials

PAXH CIK 0001350156

Source: EDGAR filings · Built 2026-09-19T01:41:04Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow -442.74K -41.52K — — — —
EBITDA -975.97K -152.12K — — — —
Working Capital -966.18K -2.34M — — — —
Net Debt 113.10K 201.33K — — — —
Gross Margin — — — — 100.00% —
Operating Margin — — — — -49087.77% -39706.33%
Net Margin — — — — -49087.77% -39706.33%
Return on Equity (ROE) 302.81% 3.50% 4.15% 6.80% 8.44% 8.33%
Return on Assets (ROA) -199.01% — -710350.00% -2604433.33% -69746.33% -407982.50%
Current Ratio 0.00× 0.00× — — — —
Debt-to-Equity -0.30× -0.09× — — — —
Effective Tax Rate 0.00% 0.00% — — — —
Cash Conversion Ratio 0.10× 0.51× 0.31× 0.24× 0.35× 0.22×
Accruals Ratio -1.78× — -4897.21× -19774.83× -450.47× -3186.90×
CapEx Coverage -0.38× — — — — —
Free Cash Flow Per Share $-0.01 $-0.00 — — — —

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenues 0 0 0 0 368 411
Cost of Goods and Services Sold — — — 0 0 —
Gross Profit — — — 0 368 —
Research and Development Expense 307.61K 0 5.63K 6.53K 25.64K 8.22K
Operating Expenses 992.70K 152.12K 99.45K 156.27K 181.01K 163.60K
Operating Income (Loss) -992.70K -152.12K -99.45K -156.27K -180.64K -163.19K
Income Tax Expense (Benefit) 0 0 0 — — —
Net Income (Loss) Attributable to Parent -1.16M -82.01K -99.45K -156.27K -180.64K -163.19K
Earnings Per Share, Basic $-0.03 $0.00 $-0.01 $-0.01 $-0.01 —
Weighted Average Number of Shares Outstanding, Basic 41.84M 19.77M 19.77M 19.77M 19.77M —
Earnings Per Share, Diluted $-0.03 $0.00 $-0.01 $-0.01 $-0.01 —
Weighted Average Number of Shares Outstanding, Diluted 41.84M 19.77M 19.77M 19.77M — —

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 1.00K 0 14 6 259 40
Assets, Current 1.00K 0 14 6 259 40
Assets 583.61K 0 14 6 259 40
Liabilities, Current 967.18K 2.34M 2.40M 2.30M 2.14M 1.96M
Liabilities 967.18K 2.34M 2.40M 2.30M 2.14M 1.96M
Stockholders' Equity Attributable to Parent -383.57K -2.34M -2.40M -2.30M -2.14M -1.96M
Common Stock, Shares, Outstanding 44.71M 19.77M 19.77M 19.77M 19.77M 19.77M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -121.16K -41.52K -30.89K -37.62K -63.97K -35.72K
Payments to Acquire Property, Plant, and Equipment 321.58K 0 — — — —
Net Cash Provided by (Used in) Investing Activities -321.58K 0 0 0 0 0
Net Cash Provided by (Used in) Financing Activities 445.58K 39.27K 30.90K 37.36K 64.19K 35.71K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PAXH CIK 0001350156), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

SPRO

Spero Therapeutics, Inc.

CBT

CABOT CORP

KO

COCA COLA CO